A retrospective study of serum KL-6 levels during treatment with biological disease-modifying antirheumatic drugs in rheumatoid arthritis patients: a report from the Ad Hoc Committee for Safety of Biological DMARDs of the Japan College of Rheumatology

By Takamura Akito  

Modern Rheumatology, Vol. 23, Iss. 2, 2013-03 ,pp. : 297-303

Springer Publishing Company

Access to resources Recommend Favorite

Reduction in serum levels of substance P in patients with rheumatoid arthritis by etanercept, a tumor necrosis factor inhibitor

By Origuchi Tomoki  

Modern Rheumatology, Vol. 21, Iss. 3, 2011-06 ,pp. : 244-250

Springer Publishing Company

Access to resources Recommend Favorite

Decrease in the levels of anti-cyclic citrullinated peptide antibody in Japanese patients with rheumatoid arthritis who responded to anti-tumor necrosis factor-α

By Onishi Sachiko   Yoshio Taku   Nagashima Takao   Minota Seiji  

Modern Rheumatology, Vol. 20, Iss. 5, 2010-10 ,pp. : 528-530

Springer Publishing Company

Access to resources Recommend Favorite

Suboptimal Clinical Response to Anti-tumor Necrosis Factor alpha (TNFα) Antibody Therapy in a Patient with Severe Rheumatoid Arthritis and Lymphadenopathy: CASE REPORT

By Saeki Yukihiko   Ohshima Shiro   Mima Toru   Sasai Mitsuko   Nishioka Katsuhiro   Shimizu Masatoshi   Suemura Masaki   McCloskey Richard   Kishimoto Tadamitsu  

Scandinavian Journal of Rheumatology, Vol. 27, Iss. 4, 1998-08 ,pp. : 303-305

Informa Healthcare

Access to resources Recommend Favorite

A case report of tumor necrosis factor-alpha antibody-induced thrombocytopenia associated with emerging IgM anticardiolipin antibody in patients with scleroderma overlap/rheumatoid arthritis

By Hamaguchi Masahide   Kawahito Yutaka   Ishino Hidetaka   Yoshida Makie   Yoshikawa Toshikazu  

Clinical Rheumatology, Vol. 26, Iss. 6, 2007-06 ,pp. : 988-990

Springer Publishing Company

Access to resources Recommend Favorite